Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S continues to escalate, according to people familiar with the matter.
Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo